Stockreport

Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]

Sutro Biopharma, Inc.  (STRO) 
Last sutro biopharma, inc. earnings: 11/8 07:00 am Check Earnings Report
PDF - Two new clinical trials, REFRaME-P1, a registration-enabling trial of luvelta for pediatric patients with rare leukemia, and REFRaME-L1, a Phase 2 trial of luvelta fo [Read more]